Open AccessAndrogen Deprivation Therapy Use and Risk of Mild Cognitive Impairment in Prostate Cancer Patients
Author(s) -
Hector J. Alonso-Quis,
Bradley J. Stish,
Jeremiah A. Aakre,
Clinton E. Hagen,
Ronald C. Petersen,
Michelle M. Mielke
Publication year - 2020
Publication title -
alzheimer disease and associated disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 95
eISSN - 1546-4156
pISSN - 0893-0341
DOI - 10.1097/wad.0000000000000415
Subject(s) - androgen deprivation therapy , prostate cancer , medicine , rochester epidemiology project , hazard ratio , proportional hazards model , confidence interval , epidemiology , population , oncology , cancer , population based study , environmental health
We examined the association between androgen deprivation therapy (ADT) use and the risk of mild cognitive impairment (MCI) among prostate cancer patients.